Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Seelos Announces Initiation of Preclinical Study of SLS-004 in Parkinson’s Disease

americanpharmaceuticalreviewJune 04, 2020

Tag: Seelos Therapeutics , Parkinson’s disease , SLS-004

PharmaSources Customer Service